Brief: Shanghai Microport Medbot Says Surgical Robot Obtained Approval For Marketing by NMPA
Dec 13 (Reuters) - Shanghai MicroPort MedBot Group Co
Ltd 2252.HK :
* R-ONE VASCULAR INTERVENTIONAL SURGICAL ROBOT OBTAINED
APPROVAL
FOR MARKETING FROM NMPA OF CHINA
Further company coverage: 2252.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai MicroPort MedBot (Group)
See all newsBrief: Shanghai Microport Medbot (Group) Says Yu Liu Resigns As Executive Director
Shanghai MicroPort jumps on semi-annual profitability expectations
Brief: Shanghai Microport Medbot (Group)Expects HY Net Profit Of RMB28 Million–RMB40 Million
Shanghai MicroPort jumps on breakthrough in core product installation
Brief: Shanghai Microport Medbot (Group) Says Toumai Remote Laparoscopic Surgery Robot Obtains EU CE Mark